The Vanguard Group Discloses Position in Spire Healthcare Group plc

The Vanguard Group, Inc. has revealed its stake in Spire Healthcare Group plc as part of its latest Form 8.3 disclosure. The filing, submitted on December 1, 2025, indicates that Vanguard holds a 3.57% interest in Spire’s 1p ordinary shares, corresponding to 14,361,485 shares. This notification is in compliance with Rule 8.3 of the UK Takeover Code, which mandates public disclosure of interests in relevant securities representing 1% or more.

The document provides details of Vanguard's recent dealings, which include the purchase of 1,764 Spire shares at 2.30 GBP per unit. No engagements in cash-settled or stock-settled derivatives were noted, nor were there any other dealing arrangements like options or indemnities reported.

No supplementary Form 8 is attached, as there are no open stock-settled derivative positions to disclose. Shawn Acker is listed as the contact person for further inquiries.